The global rise in obesity and type 2 diabetes is fueling an epidemic of MASLD and MASH, now recognized as the leading cause ...

The researchers found that the cause behind prevalence of fatty liver disease among IT employees is attributed to the ...

With the rising epidemic of obesity, metabolic syndrome, and type 2 diabetes mellitus in China, metabolic ...

Health department starting fatty liver clinics in district hospitals for early diagnosis and treatment of liver diseases.

In patients with metabolic dysfunction-associated steatotic liver disease, there is increased risk for heart failure with preserved ejection fraction.

Young adulthood obesity is associated with greater odds for MASLD, at-risk MASH, and increased liver stiffness measurement.

Researchers from Georgia Southern University's Jiann-Ping Hsu College of Public Health have discovered a positive trend in ...

Klug, M.B.A., Appointed Chief Financial Officer and Chief Business Officer; Sophie Jeannin, M.D., Appointed Chief Medical ...

Patients with celiac disease have double the incidence rate of chronic liver disease compared with those without this ...

Patients with type 1 diabetes comorbid with metabolic dysfunction-associated steatotic liver disease had a low prevalence of advanced liver fibrosis.

A 96-week clinical trial found that 300 mg of Vitamin E significantly improved liver histology and reduced inflammation in ...

"The combination of MASLD, sarcopenia, and advanced fibrosis further worsened outcomes (HR 3.41). Additionally, metabolic dysfunction-associated alcohol-related liver disease (MetALD) and other ...